Quarterly reports poured in throughout the morning, leading to significant price swings among many reporting companies, as is often the case. Among the winners were Cint and Ovzon, while Ework and Viaplay emerged as the day's report losers. Oncopeptides' report was overshadowed by the announcement that the company is carrying out a rights issue of 200 million kronor.
After 30 minutes of trading, the OMXS30 index was down 0.29 percent at 3,156.87. During the day, the index has fluctuated between a low of -0.37 percent and a high of -0.08 percent.
The broader OMXSPI was down 0.20 percent.
| Company | Change | Comment |
| Cint | 36.2 % | Higher revenue and improved EBITA result |
| Ovzon | 12.2 % | Turned to positive operating profit, order intake and revenue rose sharply |
| Truecaller | 7.3 % | Deutsche Bank upgrades to buy (hold), target price 15 kronor (21) |
| Asmodee | 5.0 % | Report consistently beat expectations |
| Latour | 1.4 % | Major shareholder Douglas purchased shares for 20 million kronor |
| Bravida | -2.1 % | Pareto Securities downgrades to hold (buy), target price 112 kronor (102) |
| Eastnine | -6.0 % | Major shareholder Bonnier Fastigheter sold shares for 554 million kronor, discount of just under 7 percent |
| Arla Plast | -6.3 % | Lower revenue and result, increases dividend |
| Garo | -9.7 % | Lower revenue, turned to operating loss in Q4 |
| Viaplay | -13.2 % | Adjusted operating profit declined in Q4 |
| Ework | -25.6 % | Lower result in Q4, sharply cuts dividend |
| Oncopeptides | -31.0 % | Carrying out a rights issue of 200 million kronor |
